Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis; dysregulation of this axis causes diabetes. PGC-1α (peroxisome-proliferator-activated receptor-γ coactivator-1α) links insulin signalling to the expression of glucose and lipid metabolic genes. The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1α and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1α. Although insulin is a mitogenic signal in proliferative cells, whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1α acetylation. Insulin/GSK-3β (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1α activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, CDK4 phosphorylation of GCN5 can lead to acetylation of PGC-1α and is associated with decreased glucose metabolism in hepatic cells (Lee et al., 2014).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Lee et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK4 regulates G1 to S phase transition and its kinase activity is dependent on its binding to one of the three D-type cyclins including cyclin D1 13 .”
BackgroundNutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Self-citationReplication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · cited 1×
“Interestingly, genome-wide association studies have revealed that mutations of CDKN2A, a CDK4 inhibitor, are significantly correlated with a high risk of type 2 diabetes 27 .”
BackgroundGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“GSK3 β , active during fasting and inactive during refeeding due to its phosphorylation by insulin-AKT signaling, negatively regulates cyclin D1 through phosphorylation of T286, causing nuclear exclusion of cyclin D1 and proteasomal degradation 19,22 .”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Self-citation(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · cited 1×
“PD 0332991, the most specific CDK4 inhibitor available 15 , led to a similar decrease of PGC-1 α acetylation (Fig.”
BackgroundMatsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 2×
“…of CKD4 activity by cyclin D1 wild-type overepxression or Cyclin D1 T286A mutant, a hyperactive mutant allele spared from proteasomal degradation 19 , but not cyclin D1 K112E (a mutant that cannot activate CDK4 kinase activity 18 ), suppressed gluconeogenic genes and glucose production,…”
Background
Cited by
Cyclin D1, cancer progression, and opportunities in cancer treatment
Qie, S., & Diehl, J. A. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1475-3 · Cited by 657
Exosomal circRNAs: biogenesis, effect and application in human diseases
Wang, Y., Liu, J., Ma, J., Sun, T., Zhou, Q., Wang, W., Wang, G., Wu, P., Wang, H., Jiang, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1041-z · Cited by 636
Insulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 587
Self-citationNon-canonical functions of cell cycle cyclins and cyclin-dependent kinases
Hydbring, P., Malumbres, M., & Sicinski, P. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.27 · Cited by 528
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Klein, M. E., Kovatcheva, M., Davis, L. E., Tap, W. D., & Koff, A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.023 · Cited by 378
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 375
Self-citationMetabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
Sun, L., Suo, C., Li, S.-T., Zhang, H., & Gao, P. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.005 · Cited by 363
p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion
Helman, A., Klochendler, A., Azazmeh, N., Gabai, Y., Horwitz, E., Anzi, S., Swisa, A., Condiotti, R., Granit, R. Z., Nevo, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4054 · Cited by 351
Protein acetylation in metabolism – metabolites and cofactors
Menzies, K. J., Zhang, H., Katsyuba, E., & Auwerx, J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.181 · Cited by 331
Interconnection between Metabolism and Cell Cycle in Cancer
Icard, P., Fournel, L., Wu, Z., Alifano, M., & Lincet, H. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.12.007 · Cited by 327
Molecular pathophysiology of hepatic glucose production
Sharabi, K., Tavares, C. D. J., Rines, A. K., & Puigserver, P. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.09.003 · Cited by 325
Self-citationRegulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X.-W., Huang, X., Song, B.-L., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 306
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
The double dealing of cyclin D1
Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278
“These processes include DNA damage response [7, 8], chromosome duplication and stability [9, 10], senescence [11, 12], autophagy [11, 13], mitochondrial respiration [14, 15], migration [16-18], metabolism [19-21], and immune surveillance [22, 23].”
BackgroundFueling the Cell Division Cycle
Salazar-Roa, M., & Malumbres, M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.08.009 · Cited by 268
Structural insights into the functional diversity of the CDK–cyclin family
Wood, D. J., & Endicott, J. A. (2018) · Open Biology · doi:10.1098/rsob.180112 · Cited by 260
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W. E., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 248
Zhang, L., Yao, Y., Zhang, S., Liu, Y., Guo, H., Ahmed, M., Bell, T., Zhang, H., Han, G., Lorence, E., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1167 · Cited by 233
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways
Gonzales, K. A. U., Liang, H., Lim, Y.-S., Chan, Y.-S., Yeo, J.-C., Tan, C.-P., Gao, B., Le, B., Tan, Z.-Y., Low, K.-Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.001 · Cited by 210
Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
Sharabi, K., Lin, H., Tavares, C. D. J., Dominy, J. E., Camporez, J. P., Perry, R. J., Schilling, R., Rines, A. K., Lee, J., Hickey, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.001 · Cited by 210
Self-citationE2F1, a Novel Regulator of Metabolism
Denechaud, P.-D., Fajas, L., & Giralt, A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00311 · Cited by 208
“Additionally, NAFLD correlated with the phosphorylation of pRB in the liver in different mouse models of obesity and diabetes (16, 61), altogether consistent with increased E2F1 activity in these conditions.”
BackgroundDiabetes mellitus—advances and challenges in human β-cell proliferation
Wang, P., Fiaschi-Taesch, N. M., Vasavada, R. C., Scott, D. K., García-Ocaña, A., & Stewart, A. F. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.9 · Cited by 205
Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene · doi:10.1038/onc.2015.407 · Cited by 204
Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma
LaGory, E. L., Wu, C., Taniguchi, C. M., Ding, C.-K. C., Chi, J.-T., von Eyben, R., Scott, D. A., Richardson, A. D., & Giaccia, A. J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.006 · Cited by 193
Dai, X., Chen, C., Yang, Q., Xue, J., Chen, X., Sun, B., Luo, F., Liu, X., Xiao, T., Xu, H., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0485-1 · Cited by 184
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
Verma, V., Jafarzadeh, N., Boi, S., Kundu, S., Jiang, Z., Fan, Y., Lopez, J., Nandre, R., Zeng, P., Alolaqi, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00818-9 · Cited by 182
Cell cycle regulators in cancer cell metabolism
Leal-Esteban, L. C., & Fajas, L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165715 · Cited by 179
Autonomous Metabolic Oscillations Robustly Gate the Early and Late Cell Cycle
Papagiannakis, A., Niebel, B., Wit, E. C., & Heinemann, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.018 · Cited by 165
Li, H.-R., Liu, Q., Zhu, C.-L., Sun, X.-Y., Sun, C.-Y., Yu, C.-M., Li, P., Deng, X.-M., & Wang, J.-F. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102745 · Cited by 163
Hannou, S. A., Wouters, K., Paumelle, R., & Staels, B. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.01.008 · Cited by 159
Yoshida, A., Lee, E. K., & Diehl, J. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2931 · Cited by 153
“In this regard, onemight first consider known substrates for the CDK4/6 kinase, which include Rb, p107, p130, FOXM1 (19), PRMT5 (42), and GCN5 (43) and how any of these intersect with mTOR signaling, given that mTORC1 suppression is necessary for senescence.”
Ma, X., Wang, L., Huang, D., Li, Y., Yang, D., Li, T., Li, F., Sun, L., Wei, H., He, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01647-5 · Cited by 146
Clark, A. S., Karasic, T. B., DeMichele, A. M., Vaughn, D. J., O’Hara, M. H., Perini, R. F., Zhang, P. J., Lal, P., Feldman, M. D., Gallagher, M., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.4701 · Cited by 144
Cdk4 and Cdk6 Couple the Cell-Cycle Machinery to Cell Growth via mTORC1
Romero‐Pozuelo, J., Figlia, G., Kaya, O., Martín-Villalba, A., & Teleman, A. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.068 · Cited by 142
Nuclear metabolism and the regulation of the epigenome
Boon, R., da Silveira, G. G., & Mostoslavsky, R. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00285-4 · Cited by 141
Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB
Wang, Y., Huang, Y., Liu, J., Zhang, J., Xu, M., You, Z., Peng, C., Gong, Z., & Liu, W. (2020) · The EMBO Reports · doi:10.15252/embr.201948335 · Cited by 131
Ramos‐García, P., Roca-Rodríguez, M. D. M., Aguilar‐Diosdado, M., & González‐Moles, M. Á. (2020) · Oral Diseases · doi:10.1111/odi.13289 · Cited by 130
Liu, M., Liu, H., & Chen, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6221 · Cited by 112
Haim, Y., Blüher, M., Slutsky, N., Goldstein, N., Klöting, N., Harman-Boehm, I., Kirshtein, B., Ginsberg, D., Gericke, M., Guiu Jurado, E., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1094597 · Cited by 106
Islet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 104
Qie, S., Yoshida, A., Parnham, S., Oleinik, N., Beeson, G. C., Beeson, C. C., Ogretmen, B., Bass, A. J., Wong, K.-K., Rustgi, A. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09179-w · Cited by 104
CDK4: a master regulator of the cell cycle and its role in cancer
Baker, S. J., Poulikakos, P. I., Irie, H. Y., Parekh, S. S., & Reddy, E. P. (2022) · Genes & Cancer · doi:10.18632/genesandcancer.221 · Cited by 91
GCN5 acetyltransferase in cellular energetic and metabolic processes
Mutlu, B., & Puigserver, P. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194626 · Cited by 88
Self-citationThe GCN5: its biological functions and therapeutic potentials
Haque, M. E., Jakaria, M., Akther, M., Cho, D.-Y., Kim, I., & Choi, D. (2021) · Clinical Science · doi:10.1042/cs20200986 · Cited by 88
Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells
The, I., Ruijtenberg, S., Bouchet, B. P., Cristobal, A., Prinsen, M. B. W., van Mourik, T., Koreth, J., Xu, H., Heck, A. J. R., Akhmanova, A. S., et al. (2015) · Nature Communications · doi:10.1038/ncomms6906 · Cited by 88
Lara‐Riegos, J., Ortiz‐López, M. G., Peña‐Espinoza, B. I., Montúfar‐Robles, I., Peña-Rico, M. Á., Sanchez-Pozos, K. A., Granados‐Silvestre, M. D. L. Á., & Menjívar, M. (2015) · Gene · doi:10.1016/j.gene.2015.03.065 · Cited by 84
State of Evidence on Oral Health Problems in Diabetic Patients: A Critical Review of the Literature
González‐Moles, M. Á., & Ramos‐García, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225383 · Cited by 82
CDK6 inhibits white to beige fat transition by suppressing RUNX1
Hou, X. S., Zhang, Y., Li, W., Hu, A. J., Luo, C., Zhou, W., Hu, J. K., Daniele, S. G., Wang, J., Sheng, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03451-1 · Cited by 80
The multifaceted role of cell cycle regulators in the coordination of growth and metabolism
Huber, K., Mestres‐Arenas, A., Fajas, L., & Leal-Esteban, L. C. (2020) · FEBS Journal · doi:10.1111/febs.15586 · Cited by 80
Mechanical force modulates macrophage proliferation via Piezo1‐AKT‐Cyclin D1 axis
Xu, H., Guan, J., Jin, Z., Yin, C., Wu, S., Sun, W. S., Zhang, H., & Yan, B. (2022) · The FASEB Journal · doi:10.1096/fj.202200314r · Cited by 73
CDK4 Phosphorylates AMPKα2 to Inhibit Its Activity and Repress Fatty Acid Oxidation
Lopez-Mejia, I. C., Lagarrigue, S., Giralt, A., Martinez-Carreres, L., Zanou, N., Denechaud, P.-D., Castillo-Armengol, J., Chavey, C., Orpinell, M., Delacuisine, B., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.034 · Cited by 71
Progress with palbociclib in breast cancer: latest evidence and clinical considerations
Rocca, A., Schirone, A., Maltoni, R., Bravaccini, S., Cecconetto, L., Farolfi, A., Bronte, G., & Andreis, D. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016677961 · Cited by 69
Pal, A., Potjer, T. P., Thomsen, S. K., Ng, H. J., Barrett, A., Scharfmann, R., James, T. J., Bishop, D. T., Karpe, F., Godsland, I. F., et al. (2015) · Diabetes · doi:10.2337/db15-0602 · Cited by 65
Gao, J., Wang, Y., Zhao, X., Chen, P., & Xie, L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15913 · Cited by 60
Lin, X., Liu, S.-B., Luo, Y., Xu, W., Zhang, Y., Zhang, T., Xue, H. Y., Zuo, W., Li, Y., Lu, B., et al. (2020) · BioMed Research International · doi:10.1155/2020/3042636 · Cited by 60
Cdkn2a deficiency promotes adipose tissue browning
Rabhi, N., Hannou, S. A., Gromada, X., Salas, E., Yao, X., Oger, F., Carney, C., López‐Mejía, I. C., Durand, E., Rabearivelo, I., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.11.012 · Cited by 57
Wen, C., Jiang, Y., Li, X., Tang, M., Wu, L., Hu, J., Pang, D., & Zeng, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b16831 · Cited by 56
Cell size homeostasis is maintained by CDK4-dependent activation of p38 MAPK
Tan, C., Ginzberg, M. B., Webster, R., Iyengar, S., Liu, S., Papadopoli, D. J., Concannon, J. B., Wang, Y., Auld, D. S., Jenkins, J. L., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.030 · Cited by 56
Wu, H., Reizel, Y., Wang, Y. J., Lapiro, J. L., Kren, B. T., Schug, J., Rao, S., Morgan, A., Herman, A., Shekels, L. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002898117 · Cited by 55
Marak, B. N., Dowarah, J., Khiangte, L., & Singh, V. P. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112571 · Cited by 55
Pettersson-Klein, A. T., Izadi, M., Ferreira, D. M. S., Červenka, I., Correia, J. C., Martínez-Redondo, V., Southern, M. R., Cameron, M. D., Kamenecka, T. M., Agudelo, L. Z., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.017 · Cited by 54
Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer
Gwak, H., Kim, Y., An, H., Dhanasekaran, D. N., & Song, Y. S. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22498 · Cited by 53
Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis
Cheung, A. H. K., Hui, C. H., Wong, K. Y., Liu, X., Chen, B., Kang, W., & To, K. F. (2022) · International Journal of Cancer · doi:10.1002/ijc.34288 · Cited by 52
Fueling the Cycle: CDKs in Carbon and Energy Metabolism
Solaki, M., & Ewald, J. C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00093 · Cited by 51
Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
Bondy‐Chorney, E., Denoncourt, A. M., Sai, Y., & Downey, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0297 · Cited by 51
Energy metabolism in skin cancers: A therapeutic perspective
Hosseini, M., Kasraian, Z., & Rezvani, H. R. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.013 · Cited by 50
Li, S., Zhang, Y., Wang, N., Guo, R., Liu, Q., Lv, C., Wang, J., Wang, L., & Yang, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-020-2408-1 · Cited by 50
CDK4-mediated MnSOD activation and mitochondrial homeostasis in radioadaptive protection
Jin, C., Qin, L., Shi, Y., Candas, D., Fan, M., Lu, C., Vaughan, A. T., Shen, R. Z., Wu, L. S., Liu, R., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.026 · Cited by 49
Kong, T., Xue, Y., Cencic, R., Zhu, X., Monast, A., Fu, Z., Pilon, V., Sangwan, V., Guiot, M., Foulkes, W. D., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0162 · Cited by 48
Atrazine promotes RM1 prostate cancer cell proliferation by activating STAT3 signaling
Hu, K., Tian, Y., Du, Y., Huang, L., Chen, J., Li, N., Liu, W., Liang, Z., & Zhao, L. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3433 · Cited by 48
Cell cycle regulation and hematologic malignancies
Dai, Y., Jin, F., Wu, W., & Kumar, S. K. (2019) · Blood Science · doi:10.1097/bs9.0000000000000009 · Cited by 48
Oudaha, K. H., Najm, M. A. A., Samir, N., Serya, R. A. T., & Abouzid, K. A. M. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103239 · Cited by 47
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Patra, S., Elahi, N., Armorer, A., Arunachalam, S., Omala, J., Hamid, I., Ashton, A. W., Joyce, D. A., Jiao, X., & Pestell, R. G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700629 · Cited by 45
Lorito, N., Bacci, M., Smiriglia, A., Mannelli, M., Parri, M., Comito, G., Ippolito, L., Giannoni, E., Bonechi, M., Benelli, M., et al. (2020) · Cells · doi:10.3390/cells9030668 · Cited by 45
Baicalin regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production
Xu, J., Li, Y., Lou, M., Xia, W., Liu, Q., Xie, G., Liu, L., Liu, B., Yang, J., & Qin, M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.018 · Cited by 45
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma
Mohanty, A. R., Sandoval, N., Phan, A. T., Nguyen, T. V., Chen, R. W., Budde, L. E., Mei, M. G., Popplewell, L. L., Pham, L. V., Kwak, L. W., et al. (2018) · Blood · doi:10.1182/blood-2018-05-851667 · Cited by 44
Zhou, P.-J., Wang, X., An, N., Wei, L., Zhang, L., Huang, X., Zhu, H. H., Fang, Y., & Gao, W. (2018) · Oncogene · doi:10.1038/s41388-018-0580-x · Cited by 44
Li, S., Xiong, P., Zhang, W., Hu, H., Tang, S., Jia, B., & Huang, W. (2022) · Molecules · doi:10.3390/molecules27175622 · Cited by 44
Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer
Sante, G. D., Rocco, A. D., Pupo, C., Casimiro, M. C., & Pestell, R. G. (2017) · Oncotarget · doi:10.18632/oncotarget.19413 · Cited by 44
Tavares, C. D. J., Sharabi, K., Dominy, J. E., Lee, Y., Isasa, M., Orozco, J. M., Jedrychowski, M. P., Kamenecka, T. M., Griffin, P. R., Gygi, S. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706200 · Cited by 44
Self-citationYang, H., Zhao, X., Zhao, L., Liu, L., Li, J., Jia, W., Liu, J., & Huang, G. (2016) · Oncotarget · doi:10.18632/oncotarget.12351 · Cited by 44
CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival
Martínez-Carreres, L., Puyal, J., Leal-Esteban, L. C., Orpinell, M., Castillo-Armengol, J., Giralt, A., Dergai, O., Moret, C., Barquissau, V., Nasrallah, A., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0708 · Cited by 43
Non-histone protein acetylation by the evolutionarily conserved GCN5 and PCAF acetyltransferases
Downey, M. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194608 · Cited by 43
Yang, Y., Chen, J., Shang, X., Feng, Z., Chen, C., Lu, J., Cai, J., Chen, Y., Zhang, J., Hao, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201901018 · Cited by 43
Self-citationLiška, F., Landa, V., Zídek, V., Mlejnek, P., Šilhavý, J., Šimáková, M., Strnad, H., Trnovská, J., Škop, V., Kazdová, L., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08798 · Cited by 42
E2F1 promotes hepatic gluconeogenesis and contributes to hyperglycemia during diabetes
Giralt, A., Denechaud, P., López‐Mejía, I. C., Delacuisine, B., Blanchet, É., Bonner, C., Pattou, F. N., Annicotte, J., & Fajas, L. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.02.011 · Cited by 42
Sakai, M., Tujimura-Hayakawa, T., Yagi, T., Yano, H., Mitsushima, M., Unoki-Kubota, H., Kaburagi, Y., Inoue, H., Kido, Y., Kasuga, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13147 · Cited by 41
Poché, R. A., Zhang, M., Rueda, E. M., Tong, X., McElwee, M. L., Wong, L. Y. E., Hsu, C., Déjosez, M., Burns, A. R., Fox, D. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.039 · Cited by 40
Chirivella, L., Kirstein, M., Ferrón, S. R., Domingo-Muelas, A., Durupt, F. C., Umanzor, C. A., Cano‐Jaimez, M., Pérez‐Sánchez, F., Barbacid, M., Ortega, S., et al. (2017) · Stem Cells · doi:10.1002/stem.2694 · Cited by 39
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells
Caillot, M., Bourgeais, J., Dakik, H., Costé, É., Mazure, N. M., Lelièvre, E., Coqueret, O., Hérault, O., Mazurier, F., & Sola, B. (2020) · Oncogenesis · doi:10.1038/s41389-020-00253-3 · Cited by 38
Santiappillai, N. T., AbuHammad, S., Slater, A. A., Kirby, L., McArthur, G. A., Sheppard, K. E., & Smith, L. K. (2021) · Cancers · doi:10.3390/cancers13030524 · Cited by 38
Jiang, Z., Shen, H., Tang, B., Yu, Q., Ji, X., & Wang, L. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.032 · Cited by 37
CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth
Yin, S., Liu, L., Ball, L. E., Wang, Y., Bedford, M. T., Duncan, S. A., Wang, H., & Gan, W. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112316 · Cited by 37
Yu, L., Xu, J., Liu, J., Zhang, H., Sun, C., Wang, Q., Shi, C., Zhou, X., Hua, D., Luo, W., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz038 · Cited by 37
CDK4/6 inhibitors in lung cancer: current practice and future directions
Lv, S., Yang, J., Lin, J., Huang, X., Zhao, H., Zhao, C., & Yang, L. (2024) · European Respiratory Review · doi:10.1183/16000617.0145-2023 · Cited by 37
Beyond cell cycle regulation: The pleiotropic function of CDK4 in cancer
Ziegler, D. V., Parashar, K., & Fajas, L. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.002 · Cited by 35
Deleye, Y., Cotte, A. K., Hannou, S. A., Hennuyer, N., Bernard, L., Derudas, B., Caron, S., Legry, V., Vallez, E., Dorchies, E., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012543 · Cited by 35
Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma
Bloedjes, T. A., de Wilde, G., & Guikema, J. E. J. (2021) · Cancers · doi:10.3390/cancers13030396 · Cited by 35
Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma?
Wu, C. L., Yang, P., Liu, B., & Tang, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s232464 · Cited by 34
Metadata
- Authors
- Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., Vazquez, F., Sicinski, P., Shulman, G. I., & Puigserver, P.
- Affiliations
- Harvard University (US)
- Yale University (US)
- Broad Institute (US)
- Corresponding author
- Puigserver, Pere
- ORCID
- Venue
- Nature
- Published
- 2014-05-25
- Volume
- 510
- Issue
- 7506
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4076706
- OpenAlex
- W2095720556
- Cited by
- 234
- References
- 36
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 9 · 2023: 16 · 2022: 15 · 2021: 14 · 2020: 29 · 2019: 28 · 2018: 26 · 2017: 25 · 2016: 20 · 2015: 20 · 2014: 5
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (2r24dk080261-06a1)
- U.S. Public Health Service (R01 069966)
- National Institute of Mental Health (R03 MH092174)
- National Institute on Drug Abuse (R03DA032468)
- National Cancer Institute (R01CA108420, R01CA083688)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK-080261, R24DK080261-06, R01DK089098, R01DK069966, U24DK059635, F32DK083871, DK059635, P30DK034989)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- cyclin D1, CDK4, insulin signaling, glucose metabolism, gluconeogenesis, PGC-1α, GCN5, histone acetylation, hepatic glucose production, glucose homeostasis, GSK3β, amino acids, diabetes mellitus, CDK4 inhibitors, cell cycle machinery, metabolic disorders
- MeSH terms
- Glycogen Synthase Kinase 3 beta, p300-CBP-Associated Factor, Acetylation, Amino Acids, Animals, Cell Cycle, Cell Nucleus, Cells, Cultured, Diabetes Mellitus, Enzyme Activation, Fasting, Gluconeogenesis, Glucose, Homeostasis, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Male, Phosphorylation, RNA, Messenger, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Deletion, Cyclin D1, Hepatocytes, Glycogen Synthase Kinase 3, Cell Line, Tumor, Cyclin-Dependent Kinase 4, Mice, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.